Experimental: Cohort 1
(28 Days) – Nab-paclitaxel ,Gemcitabine, Capecitabine, Cisplatin and Irinotecan
Drug: Nab-paclitaxel
IV over 30 minutes; Days 1 and 15
Other Name: Abraxane
Drug: Gemcitabine
IV over 30 minutes; Days 1 and 15
Other Name: Gemzar
Drug: Capecitabine
PO twice daily (BID); Days 1-7, 15-21
Other Name: Xeloda
Drug: Cisplatin
IV over 60 minutes; Days 1 and 15
Other Name: Platinol
Drug: Irinotecan
IV over 30 minutes; Days 1 and 15
Other Name: Camptosar
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
